287119-83-9

Basic information

• Product Name: 2-(2-Methyl-5-nitrophenyl)aceticacid
• Synonyms: 2-Methyl-5-nitrophenylacetic acid;Benzeneacetic acid, 2-Methyl-5-nitro-
• CAS NO: 287119-83-9
• Molecular Formula: C₉H₉NO₄
• Molecular Weight: 195.17206
• Mol File: 287119-83-9.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 400.385 °C at 760 mmHg
• Flash Point: 178.807 °C
• Appearance: /
• Density: 1.346 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.587
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-(2-Methyl-5-nitrophenyl)aceticacid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-Methyl-5-nitrophenyl)aceticacid(287119-83-9)
• EPA Substance Registry System: 2-(2-Methyl-5-nitrophenyl)aceticacid(287119-83-9)

Safety Data

• Hazardous Substances Data: 287119-83-9(Hazardous Substances Data)

Usage

General Description

2-(2-Methyl-5-nitrophenyl)aceticacid is a chemical compound with the molecular formula C10H11NO4. It is a yellow crystalline solid with a melting point of 130-132°C. 2-(2-Methyl-5-nitrophenyl)aceticacid is commonly used in organic synthesis and pharmaceutical research. It is also a versatile intermediate for the synthesis of various biologically active compounds. The presence of a nitro group in the molecule makes it useful in the preparation of drugs and agrochemicals. Additionally, it has been studied for its potential anti-inflammatory and analgesic properties. Overall, 2-(2-Methyl-5-nitrophenyl)aceticacid is a valuable chemical with important applications in the pharmaceutical and research industries.

InChI:InChI=1/C9H9NO4/c1-6-2-3-8(10(13)14)4-7(6)5-9(11)12/h2-4H,5H2,1H3,(H,11,12)

Upstream product

• 1975-52-6 5-nitro-o-toluic acid 
• 22474-47-1 (2-methyl-5-nitro-7-phenyl)methanol 
• 409082-10-6 (2-methyl-5-nitrophenyl)-methyl methylsulfonate 
• 409082-11-7 2-(2-methyl-5-nitrophenyl)acetonitrile 
• 644-36-0 o-methylphenylacetic acid 

Downstream Products

• 287119-84-0 2-methyl-5-nitrophenylacetic acid methyl ester 
• 287119-94-2 methyl 2-methyl-5-[N-methyl-N-(4-nitrobenzyloxycarbonyl)]aminophenylacetate 
• 287119-98-6 2-methyl-5-[N-methyl-N-(4-nitrobenzyloxycarbonyl)]aminophenylacetic acid 
• 287120-10-9 N-[2-(N,N-dimethylamino)ethyl]-2-methyl-5-[N-methyl-N-(tert-butyloxycarbonyl)]aminophenylacetamide 
• 287120-06-3 2-methyl-5-[N-methyl-N-(tert-butyloxycarbonyl)]aminophenylacetic acid 
• 287120-02-9 methyl 2-methyl-5-[N-methyl-N-(tert-butyloxycarbonyl)]aminophenylacetate 
• 287119-90-8 methyl 2-methyl-5-(N-methylamino)phenylacetate 
• 850449-93-3 methyl 2-(5-amino-2-methylphenyl)acetate 
• 850450-21-4 N-(4-methyl-3-{1-methyl-7-[3-(4-methyl-piperazin-1-y)-phenylamino]-2-oxo-1,2-dihydro-[1,6]naphthyridin-3-yl}-phenyl)-3-trifluoromethyl-benzamide 
• 850450-20-3 N-{3-[7-(3-dimethylaminomethyl-phenylamino)-1-methyl-2-oxo-1,2-dihydro-[1,6]naphthyridin-3-yl]-4-methyl-phenyl}-3-trifluoromethyl-benzamide 
• 850450-17-8 N-{3-[7-(6-methoxy-pyridin-3-ylamino)-1-methyl-2-oxo-1,2-dihydro-[1,6]naphthyridin-3-yl]-4-methyl-phenyl}-3-trifluoromethyl-benzamide 
• 850451-23-9 N-[3-(7-benzylamino-1-methyl-2-oxo-1,2-dihydro-[1,6]naphthyridin-3-yl)-4-methyl-phenyl]-3-trifluoromethyl-benzamide 
• 850450-18-9 N-[3-(7-ethylamino-1-methyl-2-oxo-1,2-dihydro-[1,6]naphthyridin-3-yl)-4-methyl-phenyl]3-trifluoromethyl-benzamide 

Relevant articles and documents

(PYRIDIN-2-YL)AMINE DERIVATIVES AS TGF-BETA R1 (ALK5) INHIBITORS FOR THE TREATMENT OF CANCER

The present invention relates to pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment and/or prevention of a proliferation disorder associated with ΤGFβR1 activity, such as a cancer or fibrosis. The invention provides compounds of Formula (I) and Formula (II) as further described herein having an acidic moiety that enhances tissue specificity for targeted tissues and organs. The invention includes pharmaceutical compositions, pharmaceutical combinations, and methods of use of these compounds for treating conditions including cancer or fibrosis.

RORGAMMA MODULATORS AND USES THEREOF

The present invention provides novel compounds of formula (la) that are modulators of RORgamma. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the modulation of RORgamma has therapeutic effects, for instance in autoimmune diseases, autoimmune-related diseases, inflammatory diseases, metabolic diseases, fibrotic diseases, or cholestatic diseases.

IMIDAZOPYRIDAZINECARBONITRILES USEFUL AS KINASE INHIBITORS

The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.